Interesting ImagesReal-Time DMSA-SPECT/US Fusion Imaging Revealing Nonscarring Loss of Function After PyelonephritisFreesmeyer, Martin MD*; Weigel, Friederike MD†; John, Ulrike MD†; Mentzel, Hans-Joachim MD‡; Gühne, Falk MD*Author Information From the *Clinic of Nuclear Medicine †Pediatric Nephrology ‡Pediatric Radiology, Jena University Hospital, Jena, Germany. Received for publication April 29, 2019; revision accepted February 16, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Martin Freesmeyer, MD, Clinic of Nuclear Medicine, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany. E-mail: email@example.com. Online date: April 23, 2020 Clinical Nuclear Medicine: June 2020 - Volume 45 - Issue 6 - p e274-e275 doi: 10.1097/RLU.0000000000003023 Buy Metrics Abstract Using real-time SPECT/US fusion imaging, the localization of an uptake defect in DMSA scan could be identified unambiguously after being uncertain in ultrasound alone. Thereby, a localized functional loss, due to history of pyelonephritis, without scarring, but reduced cortical thickness could be verified. DMSA-SPECT/US primarily demonstrates its utility in depiction of renal pathologies and may be a descriptive tool in equivocal constellation of findings. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.